Emerging viewpoints from contemporary research on terrestrial fungal metabolites provides
an insight into their valuable insidious biological activity including cancer therapeutics …

Covering: 1964 to 2013 Natural products from bacteria and plants have played a leading
role in cancer drug discovery resulting in a large number of clinically useful agents. In …

Background: Fungi are a well-known and valuable source of compounds of therapeutic
relevance, in particular of novel anticancer compounds. Although seldom obtainable …

Many fungal metabolites show promising anticancer properties both in vitro and in animal
models, and some synthetic analogs of those metabolites have progressed into clinical …

Although fungi produce highly structurally diverse metabolites, many of which have served
as excellent sources of pharmaceuticals, no fungi‐derived agent has been approved as a …

Natural products play an important role in the development of anticancer drugs. To date,
predominantly metabolites from plants and bacteria served as lead structures for anticancer …

The rapid progress in understanding the molecular biology of cancer has made a large
impact on the design and development of novel therapeutic strategies prompted by the multi …

Secondary metabolites from fungi have been purified, characterized, and further modified in
their moieties as anticancer agents. In the last few decades, fungal metabolites have …

The exploitation of the antitumor properties of fungal secondary metabolites is one of the
fundamental objectives pursued by a multiplicity of research groups and laboratories …

The diversity of fungi represents a fabulous and remarkable asset of sources of bioactive
compounds with vast potential for pharmaceutical applications. Especially in Oncology …